|
2025
|
Invention
|
Methods of reducing plasma level of macrophage migratory inhibitor factor in patients.
Disclosed... |
|
2024
|
Invention
|
Treatment of progressive neurodegenerative disease with ibudilast.
Compositions and methods for ... |
|
2023
|
Invention
|
Injectable formulations of ibudilast.
A injectable pharmaceutical compositions consists of a buf... |
|
|
Invention
|
Injectable formulations of ibudilast. A injectable pharmaceutical compositions consists of a buff... |
|
|
Invention
|
Methods of treating post-covid condition(s). Disclosed is a method of treating post-COVID conditi... |
|
|
Invention
|
Ibudilast for use in the treatment of post-covid conditions. A method of treating post-COVID cond... |
|
2022
|
Invention
|
Ibudilast in combination therapy for use in the treatment of glioblastoma. Disclosed herein are c... |
|
|
Invention
|
Methods of treating glioblastoma multiforme using combination therapy.
Disclosed herein are comp... |
|
|
Invention
|
Methods of minimizing cancer metastasis. A method of preventing metastasis of a cancer in a patie... |
|
|
Invention
|
Ibudilast for preventing eye cancer metastasis. A method of preventing metastasis of a cancer in ... |
|
|
Invention
|
Methods of preventing cancer metastasis. A method of preventing metastasis of a cancer in a patie... |
|
|
Invention
|
Methods to decrease triglyceride synthesis in the liver. Described herein are methods for decreas... |
|
|
Invention
|
Phenoxyalkylcarboxylic acid derivatives and their use in lowering triglyceride levels. Described ... |
|
|
Invention
|
Methods of treating chemical gas exposure. A method of treating chemical-induced lung injury in a... |
|
|
Invention
|
Methods of treating chemical gas exposure. Disclosed is a method of treating chemical-induced lun... |
|
2021
|
Invention
|
Treatment of progressive neurodegenerative disease with ibudilast. Compositions and methods for t... |
|
|
Invention
|
Methods of reducing plasma level of macrophage migratory inhibitory factor in patients with ibudi... |
|
|
Invention
|
Methods of reducing plasma level of macrophage migratory inhibitory factor in patients. Disclosed... |
|
2020
|
Invention
|
Ibudilast oral formulations and methods of using same. This disclosure is directed to ibudilast h... |
|
|
Invention
|
Methods of suppressing myeloid-derived suppressor cells in patients.
Methods of suppressing myel... |
|
|
Invention
|
Methods and dosing regimens using ibudilast and a second agent for cancer therapy. Methods and do... |
|
|
Invention
|
Combination of ibudilast and riluzole and methods of using same. The present disclosure relates g... |
|
2019
|
Invention
|
Methods of treating ophthalmic disease/disorder or injury with ibudilast. This disclosure is dire... |
|
|
Invention
|
Combination of ibudilast and interferon-beta and methods of using same. This disclosure is direct... |
|
|
Invention
|
Methods of treating glioblastoma multiforme using ibudilast.
Compositions and methods for treati... |
|
|
Invention
|
Combination of ibudilast and riluzole and methods of using same.
The present disclosure relates ... |
|
|
Invention
|
Methods of suppressing myeloid-derived suppressor cells in patients. Methods of suppressing myelo... |
|
2017
|
Invention
|
Methods of treating glioblastoma multiforme using ibudilast. Compositions and methods for treatin... |
|
|
Invention
|
Method of treating idiopathic pulmonary fibrosis.
A compound of Formula (I):
A compound of For... |
|
|
Invention
|
Treatment of alcoholism and depression and/or dysphoric mood using ibudilast.
Alcoholism, and sy... |
|
|
Invention
|
Treatment of alcoholism and depression and/or dysphoric mood using ibudilast. Alcoholism, and sym... |
|
2015
|
Invention
|
Method of inhibiting or treating fibrosis. A therapeutic use of trans-geranylgeranylacetone and i... |
|
|
Invention
|
A combination of geranygeranylacetone, ibudilast, and riluzole and methods of using same. The pre... |
|
|
Invention
|
Geranygeranylacetone and analogs thereof and phenoxyalkylcarboxlic acids for treating fibrosis. G... |
|
|
Invention
|
Ibudilast and telmisartan for treating non-alcoholic fatty liver disease, non alcoholic steatohep... |
|
|
Invention
|
Combination of geranylgeranylacetone and ibudilast and methods of using same.
The present invent... |
|
|
Invention
|
A combination of geranylgeranylacetone and ibudilast and methods of using same. The present inven... |
|
2000
|
G/S
|
Research, conducting clinical trials, and new product development all in the field of pharmaceuti... |
